APH vs BOLT · P/E 40, rev $23.09B vs rev $7.7M
Amphenol Corporation (APH) versus Bolt Biotherapeutics (BOLT) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
APH currently screens at market cap $170.77B and trailing P/E 39.9. BOLT currently screens at market cap $11.3M.
Not investment advice. Open the APH and BOLT stock pages for the full models.
Not investment advice.